Thirona BV and Pulmonx Corporation have extended their long-running strategic partnership.

Read the new paper on the added value of AI-based lung segmentation and VR technology in lung cancer surgery planning.

We are proud to inform that we have just closed a financing round with Belgian investment fund HERAN Partners and Borski Fund from the Netherlands.

Thirona is present during the congress of the American Thoracic Society from May 14-19.

Healthcare professionals at Leiden University Medical Centre can now use artificial intelligence to quickly and easily calculate whether a corona patient has suffered serious lung damage.

Due to COVID-19 further spread worldwide, we prepared an update on our work to better bridge the gap between medical image analysis and clinical use-ability.

Our CAD4COVID software will help to assess affected lung tissue in COVID-19 patients.

The patent allows Thirona to develop an AI algorithm that will analyse CT scans to identify even the smallest abnormalities in the lungs, especially early on, ensuring that the right treatment can follow.

Public-private consortium P4O2 together with Thirona investigates risk factors for developing lung damage and chronic complaints after COVID-19 

MedicalVR has integrated Thirona's chest CT analysis software in their virtual reality application PulmoVR.